Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00068718

Locations


United States, Oregon
	Oregon Health and Science University Cancer Institute	Recruiting
	Portland, Oregon, United States, 97239-3098
	Contact: Clinical Trials Office - Oregon Health and Science University 503-494-1080 trials@ohsu.edu

United States, Washington
	Fred Hutchinson Cancer Research Center	Recruiting
	Seattle, Washington, United States, 98109-1024
	Contact: Brenda Sandmaier, MD 206-667-4961
	Seattle Cancer Care Alliance	Recruiting
	Seattle, Washington, United States, 98109-1023
	Contact: Clinical Trials Office - Seattle Cancer Care Alliance 800-804-8824
	University of Washington School of Medicine	Recruiting
	Seattle, Washington, United States, 98195
	Contact: Clinical Trials Office - University of Washington School of Me 206-616-8289
	Veterans Affairs Medical Center - Seattle	Recruiting
	Seattle, Washington, United States, 98108
	Contact: Thomas R. Chauncey, MD, PhD 206-762-1010

United States, Wisconsin
	Medical College of Wisconsin Cancer Center	Recruiting
	Milwaukee, Wisconsin, United States, 53226
	Contact: Clinical Trials Office - Medical College of Wisconsin Cancer C 414-805-4380

Germany
	Universitaet Leipzig	Recruiting
	Leipzig, Germany, D-04103
	Contact: Dietger Niederwieser, MD 49-341-971-3050 dietger@medizin.uni_leipzig.de

Italy
	Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino	Recruiting
	Turin, Italy, 10126
	Contact: Benedetto Bruno, MD, PhD 39-339-112-9064 benedetto.bruno@unito.it

Sponsors and Collaborators

Fred Hutchinson Cancer Research Center

National Cancer Institute (NCI)

Investigators


Principal Investigator:	Brenda Sandmaier, MD	Fred Hutchinson Cancer Research Center